
An ROI Moment: Submit The 510(k) or PMA Before The Patent, Or Wait For The Patent?
April 20, 2026
A New Way of Business: Why is a Service Provider Buying the Patent?
April 27, 2026Medical Patents Broker Inc.
By Kenneth Pearce, President
To begin with, a medical patent is the intangible bedrock—the foundation for every transfer. In this industry, the limited monopoly belongs to the owner of that foundation. But as many are discovering, owning the foundation is not the same as building the house.
Because MPB is in its first year, many viewers are asking: "What can your marketplace actually do for me?" The answer is that we provide the "Meeting of the Minds" for deals where there is no A-list alternative.
The "Limbo" Problem: Beyond the A-List
Suppose an individual owner, a startup, or a university is fortunate enough to license their technology to a Phase I company. Phase I is successful, but the Phase I company’s customary "A-List" of Phase II partners shows no interest. In the past, that technology would likely stall.
MPB’s marketplace provides exposure to a different pool of Phase II and Phase III companies. In our Portals, your technology can be viewed publicly or by secure request. As the adage goes, "a picture is worth a thousand words"—and in the marketplace, a well-placed listing can be money in the bank.
Three Real-World Scenarios on the MPB Marketplace:
- The VC "De-Risking" Play Venture Capitalists want to de-risk their portfolio by exiting a current limited monopoly. A listing on MPB allows them to find a potential buyer. Conversely, a VC can use our marketplace to spot an "undervalued" invention they can buy, polish, and turn over for a profit.
- The CRO as an Acquirer A Contract Research Organization (CRO) might view a medical invention owned by a smaller company or a solo inventor and determine it is a perfect fit for their specific Phase model. Instead of just being a "service provider," the CRO uses the MPB marketplace to license or buy the asset directly, becoming a partner in the success.
- The Insurance "Risk Tolerance" Match In 2026, the United States has a multitude of insurance companies covering, believe it or not, defense and abatement insurance for intellectual property owners. On MPB’s marketplace, a carrier may determine that a specific medical patent fits their "Risk Tolerance" perfectly, providing the necessary coverage to make a deal happen.
The President’s Viewpoint
Whether you are a Phase I-III company, a Class II or III company, a university, a solo inventor, a midcap or an international conglomerate, the MPB marketplace is designed to provide the space for your technology to move to the next level.
Orchestrating Technology To The Patient℠ is our mission.
Your responses are solicited.




